Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
1.60 USD
↗ 0.01 (0.63%)AT CLOSE (03:59 PM EDT)
1.57
↘ 0.03 (1.69%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
1.57
↘ 0.03 (1.69%)
🔴Market: CLOSED

LGVN is currently priced at $1.60. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, LGVN appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$1.58
High?$1.68
Low?$1.48
Prev. Close?$1.59
Volume?64.4K
Avg. Volume?150.3K
VWAP?$1.61
Rel. Volume?0.43x
Bid / Ask
Bid?$1.50 × 100
Ask?$1.65 × 100
Spread?$0.15
Midpoint?$1.58
Valuation & Ratios
Market Cap?5.1M
Shares Out?N/A
Float?2.6M
Float %?85.7%
P/E Ratio?N/A
P/B Ratio?0.49
EPS?-$7.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
5.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
35
Short Sent.?
91
Piotroski F-Score?2/9Weak
Altman Z-Score?-16.82Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.09%Low
Short Interest?106.8K
Days to Cover?1.0
Free Float2.6M
Avg Daily Volume286.6K
Settlement Date2026-09-30
Financial Health
Current Ratio?2.23Strong
Quick Ratio?2.23Strong
Cash Ratio?1.98Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.49CHEAP▾
P/S?
Peers
100
S&P
35
4.30FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-4.19CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-225.7%WEAK▾
ROA?
S&P
3
-151.6%WEAK▾
Cash Flow & Enterprise
FCF?$-20534000
Enterprise Value?$-4975883
Fundamentals ratios updated end of day
MarketsMoversWatchlist